ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W206. A total of 55 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,448,184 | -17.1% | 1,764,896 | +3.9% | 0.00% | – |
| Q2 2023 | $12,604,131 | +143.6% | 1,698,670 | +210.3% | 0.00% | – |
| Q1 2023 | $5,173,715 | +0.7% | 547,483 | +13.5% | 0.00% | – |
| Q4 2022 | $5,137,581 | +175.2% | 482,402 | +90.8% | 0.00% | – |
| Q3 2022 | $1,867,000 | +67.6% | 252,854 | +9.1% | 0.00% | – |
| Q2 2022 | $1,114,000 | -5.6% | 231,816 | +0.4% | 0.00% | – |
| Q1 2022 | $1,180,000 | -14.0% | 230,950 | +1.1% | 0.00% | – |
| Q4 2021 | $1,372,000 | -29.4% | 228,332 | +4.1% | 0.00% | – |
| Q3 2021 | $1,943,000 | +10.4% | 219,243 | -1.5% | 0.00% | – |
| Q2 2021 | $1,760,000 | +15.6% | 222,532 | +11.4% | 0.00% | – |
| Q1 2021 | $1,522,000 | -2.2% | 199,833 | +0.1% | 0.00% | – |
| Q4 2020 | $1,556,000 | -19.0% | 199,654 | +0.7% | 0.00% | – |
| Q3 2020 | $1,921,000 | – | 198,320 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sentinus, LLC | 149,050 | $1,408,523 | 0.47% |
| Intrepid Financial Planning Group LLC | 19,000 | $179,550 | 0.09% |
| PERRITT CAPITAL MANAGEMENT INC | 12,000 | $113,400 | 0.06% |
| Interchange Capital Partners, LLC | 11,413 | $107,853 | 0.06% |
| Virtu Financial LLC | 21,650 | $205 | 0.02% |
| CREATIVE FINANCIAL DESIGNS INC /ADV | 15,000 | $141,750 | 0.02% |
| J. Goldman & Co LP | 42,228 | $399,055 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 63,966 | $604,479 | 0.02% |
| KENNEDY CAPITAL MANAGEMENT LLC | 46,311 | $437,639 | 0.01% |
| 683 Capital Management, LLC | 16,000 | $151,200 | 0.01% |